Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xuefengdan dripping pills in stable exertional angina
CTR20130653Phase 2Active
- Sponsor
- Shanghai Leyu Biotechnology
- Start
- Mar 2014
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Xuefengdan Dripping Pills in stable angina, coronary arteriosclerosis, sponsored by Shanghai Leyu Biotechnology. Started Mar 2014; status: active.
02
Drugs
Xuefengdan Dripping Pills
03
Conditions
stable anginacoronary arteriosclerosis
Beyond the preview
Go deeper on CTR20130653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130653.